Krupa K Patel-Lippmann, Akshya Gupta, Marisa F Martin, Catherine H Phillips, Katherine E Maturen, Priyanka Jha, Elizabeth A Sadowski, Erica B Stein
{"title":"The Roles of Ovarian-Adnexal Reporting and Data System US and Ovarian-Adnexal Reporting and Data System MRI in the Evaluation of Adnexal Lesions.","authors":"Krupa K Patel-Lippmann, Akshya Gupta, Marisa F Martin, Catherine H Phillips, Katherine E Maturen, Priyanka Jha, Elizabeth A Sadowski, Erica B Stein","doi":"10.1148/radiol.233332","DOIUrl":null,"url":null,"abstract":"<p><p>The Ovarian-Adnexal Reporting and Data System (O-RADS) is an evidence-based clinical support system for ovarian and adnexal lesion assessment in women of average risk. The system has both US and MRI components with separate but complementary lexicons and assessment categories to assign the risk of malignancy. US is an appropriate initial imaging modality, and O-RADS US can accurately help to characterize most adnexal lesions. MRI is a valuable adjunct imaging tool to US, and O-RADS MRI can help to both confirm a benign diagnosis and accurately stratify lesions that are at risk for malignancy. This article will review the O-RADS US and MRI systems, highlight their similarities and differences, and provide an overview of the interplay between the systems. When used together, the O-RADS US and MRI systems can help to accurately diagnose benign lesions, assess the risk of malignancy in lesions suspicious for malignancy, and triage patients for optimal management.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1148/radiol.233332","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
The Ovarian-Adnexal Reporting and Data System (O-RADS) is an evidence-based clinical support system for ovarian and adnexal lesion assessment in women of average risk. The system has both US and MRI components with separate but complementary lexicons and assessment categories to assign the risk of malignancy. US is an appropriate initial imaging modality, and O-RADS US can accurately help to characterize most adnexal lesions. MRI is a valuable adjunct imaging tool to US, and O-RADS MRI can help to both confirm a benign diagnosis and accurately stratify lesions that are at risk for malignancy. This article will review the O-RADS US and MRI systems, highlight their similarities and differences, and provide an overview of the interplay between the systems. When used together, the O-RADS US and MRI systems can help to accurately diagnose benign lesions, assess the risk of malignancy in lesions suspicious for malignancy, and triage patients for optimal management.
卵巢-附件报告和数据系统(O-RADS)是一个以证据为基础的临床支持系统,用于评估中等风险女性的卵巢和附件病变。该系统包含 US 和 MRI 两部分,具有独立但互补的词典和评估类别,可用于分配恶性肿瘤风险。US 是一种合适的初始成像方式,O-RADS US 可以准确帮助确定大多数附件病变的特征。核磁共振成像是 US 的重要辅助成像工具,O-RADS 核磁共振成像可帮助确诊良性病变,并对有恶变风险的病变进行准确分层。本文将回顾 O-RADS US 和 MRI 系统,强调它们的异同,并概述这两个系统之间的相互作用。O-RADS US 和 MRI 系统结合使用,有助于准确诊断良性病变,评估恶性可疑病变的恶性风险,并对患者进行分流,以便进行最佳治疗。
期刊介绍:
Published regularly since 1923 by the Radiological Society of North America (RSNA), Radiology has long been recognized as the authoritative reference for the most current, clinically relevant and highest quality research in the field of radiology. Each month the journal publishes approximately 240 pages of peer-reviewed original research, authoritative reviews, well-balanced commentary on significant articles, and expert opinion on new techniques and technologies.
Radiology publishes cutting edge and impactful imaging research articles in radiology and medical imaging in order to help improve human health.